Brief: Lexicon Pharmaceuticals Announces Strategic Repositioning

Lexicon Pharmaceuticals

13/08/2024 13:55

Aug 13 (Reuters) - Lexicon Pharmaceuticals Inc  LXRX.O :
    * LEXICON PHARMACEUTICALS ANNOUNCES STRATEGIC REPOSITIONING
TO
DRIVE VALUE AND GROWTH OF COMMERCIAL PORTFOLIO
    * EFFORTS EXPECTED TO REDUCE 2025 OPERATING COSTS BY $40
MILLION
    * EFFORTS EXPECTED TO REDUCE 2025 OPERATING COSTS BY $40
MILLION
    * REDUCTION OF HEADCOUNT BY MORE THAN 75, OR ABOUT 50% OF
ITS
CURRENT FIELD FORCE

Source text for Eikon:  ID:nGNXbSb17l 
Further company coverage:  LXRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))